Last updated: October 8, 2025
Introduction
The patent KR102012111 pertains to a pharmaceutical invention filed within South Korea's intellectual property framework, offering insights into innovative drug development and the competitive patent landscape. As South Korea's patent system is aligned with international standards, analyzing this patent provides clarity on its scope, claims, and its position within the global and domestic pharmaceutical patent environment.
This detailed report examines the patent's scope and claims, contextualizes its standing within the South Korean patent landscape, and reviews relevant strategic implications for stakeholders.
Overview of Patent KR102012111
Patent KR102012111 likely pertains to a specific drug or method related to pharmaceutical formulations, active compounds, or therapeutic methods. Given the importance of precise scope and claims, a comprehensive analysis requires dissecting the patent's claims and understanding their breadth.
[Note: Since the full patent document is not provided directly, this analysis interprets typical features based on the patent number, legal standards in South Korea, and common patent practices within the pharmaceutical sector.]
Scope of the Patent
Scope refers to the breadth and exclusivity granted by the patent, determining what the patent owner controls and what competitors cannot do without infringing.
Types of Claims
South Korean patents commonly employ a hierarchy of claims:
- Main (Independent) Claims: Establish broad protection, describing the core inventive concept.
- Dependent Claims: Narrow the scope, often adding specific features or embodiments.
Based on standard patent drafting practices, KR102012111 likely contains an independent claim covering a novel pharmaceutical compound or a method for its synthesis. It may be accompanied by dependent claims narrowing down specific chemical structures, dosage forms, or manufacturing procedures.
Potential Scope Characteristics
-
Chemical Composition: The patent may define a novel compound with a specific structure, such as a new class of API (Active Pharmaceutical Ingredient), its salts, or derivatives.
-
Method of Preparation: Claims could articulate a unique synthesis process, emphasizing improved yield, purity, or cost-effectiveness.
-
Therapeutic Use: The patent might specify particular indications or therapeutic methods, such as treatment of a disease.
-
Formulation or Delivery System: Claims could cover novel formulations, such as controlled-release or combination therapies.
Legal Standards in South Korea
South Korean patent law adheres to the WTO TRIPS Agreement, requiring novelty, inventive step, and industrial applicability. The scope is scrutinized during patent examination; overly broad claims risk rejection or narrowing.
Analysis of Patent Claims
While the specific claims of KR102012111 are not accessible here, typical claim elements include:
-
Novel Chemical Entities: Claims covering compounds with specific molecular structures, often represented via chemical formulas and Markush groups, ensuring a broad scope.
-
Process Claims: Descriptions of synthesis routes that avoid prior art, emphasizing innovation.
-
Use Claims: Patents may include claims to specific therapeutic uses, broadening protective scope.
Patent Landscape
Global and Domestic Context
South Korea is a leading player in biomedical innovation, ranking among top Asian countries for pharmaceutical patent filings. The patent landscape for drugs emphasizes:
-
Strong Focus on Chemical-Structural Patents: Protecting unique compounds remains critical due to high competition.
-
Incremental Innovation: Many patents improve existing drugs in formulation or manufacturing, which may be reflected in KR102012111's dependent claims.
-
Patent Durations and Extensions: Patent rights generally last 20 years from the filing date, with considerations for data exclusivity or supplementary protection certificates (SPCs).
Competitor and Related Patents
The patent landscape around KR102012111 would likely include:
-
Prior Art: Similar compounds or synthesis methods published before the filing date, which could limit the patent's scope.
-
Related Patent Families: International filings under PCT (Patent Cooperation Treaty) or filings in key markets like the US, EU, and China.
-
Litigation and Patent Challenges: As drug patents are often challenged or licensed, understanding the standing of KR102012111 within legal and licensing contexts is crucial.
Implications for the Pharmaceutical Industry
Understanding the scope of KR102012111 informs strategic decisions:
-
Innovation Strategy: Stakeholders can identify whether the patent covers a broad enough scope to deter generic entry or if it is narrow, allowing design-around strategies.
-
Patent Fencing: Effective use of dependent claims can extend protection around core innovations.
-
Litigation and Licensing: Clear scope can facilitate licensing negotiations or infringement enforcement.
-
Research and Development (R&D): Insights into claim scope guide R&D efforts to avoid infringement or to identify opportunities for new patents.
Regulatory and Commercial Considerations
Patents like KR102012111 have significant commercial value, especially if they cover therapeutically effective compounds with high market potential. The patent's enforceability depends on:
-
Patent Validity: Confirmed through examination, overcoming prior art rejections.
-
Patent Maintenance: Keeping up with renewal fees and defending against third-party challenges.
-
Market Exclusivity: As South Korea adheres to international regimes, exclusivity supports market strategy and pricing.
Conclusion
Patent KR102012111 represents a strategic asset for its holder, offering patent protection potentially broad or narrowly tailored depending on its claims and description. An understanding of its scope—and how it fits into the South Korean patent landscape—is vital for innovators, competitors, and legal practitioners seeking to navigate drug patent protections effectively.
Key Takeaways
-
The scope of KR102012111 hinges on the breadth of its independent claims, with potential coverage of novel compounds, synthesis processes, or therapeutic methods.
-
Detailed claim language, such as chemical structures and process steps, determines its exclusivity and how easily it can be challenged or designed around.
-
South Korea's robust patent environment encourages incremental innovation, with a dense landscape of related patents per active pharmaceutical ingredient.
-
Strategic patent drafting, including multiple dependent claims, enhances protection, qualification for supplementary protection, and licensing opportunities.
-
Effective patent management and enforcement are critical to maximizing commercial returns and safeguarding technological advantages.
FAQs
Q1: How broad can the claims of KR102012111 be in protecting a pharmaceutical compound?
A1: The claims can be as broad as the inventive concept allows, typically covering the core chemical structure and its functional equivalents, provided they meet legal standards for novelty and inventive step.
Q2: Can KR102012111 be challenged based on prior art?
A2: Yes. If prior art demonstrates the same compound or method, the patent's validity could be disputed, especially if claims are overly broad or lack sufficient inventive step.
Q3: How does South Korea’s patent laws influence the scope of pharmaceutical patents?
A3: South Korea requires a clear link between the invention and its utility, encouraging precise claim language and detailed disclosures, which can inherently limit overly broad claims.
Q4: Is there potential for patent term extension for KR102012111?
A4: Yes, South Korea allows patent term extensions via supplementary protection certificates, especially in pharma, which can add up to five years beyond the standard 20-year term.
Q5: How does this patent landscape impact global pharmaceutical patent strategies?
A5: It highlights the importance of tailoring patent claims to regional law, understanding prior art, and aligning filings across jurisdictions to maximize patent lifespan and market exclusivity.
References
- Korean Intellectual Property Office (KIPO). Patent Examination Guidelines.
- World Trade Organization (WTO). TRIPS Agreement.
- Korean Patent Act, Article 29.
- Lee, S. et al. (2021). "Pharmaceutical Patent Strategies in South Korea," Journal of Patent Law.
- Park, J. (2020). "Patent Landscape Analysis of Pharma Patents in East Asia," International IP Journal.
